Abstract
Recently short-term power spectral analysis of heart rate variability (HRV) has been used also to stratify the risk of sudden death in subjects with chronic heart failure (CHF). Short-term spectral analysis of RR variability in normotensive healthy subjects shows two distinct components of HRV: high-frequency power (HF), which synchronizes with breathing and therefore reflects vagal modulation of the sinus node, and low-frequency power (LF) oscillating around 0.1 Hz influenced also, though not solely, by sympathetic modulation of the sinus node. Among factors that strongly influence autonomic control of the sinus node and HRV are aging, hypertension and CHF. CHF, markedly reduces both spectral components of HRV and the paradoxical LF reduction is a risk factor for sudden death. It is reasonable that, in a next future, LF could become a useful tool to identify more precisely subjects at high risk of sudden death in various cardiovascular conditions.
Keywords: oscillations, cardiomyopathy, ultra-low-frequency (ULF), Coronary artery disease, hypertension
Related Journals
Related eBooks
Related Articles
-
Development of Nitrendipine Nanoliposome for Transdermal Drug Delivery: Preparation, Characterization and Permeation Studies
Drug Delivery Letters Treatments for Obesity-Related Hypertension
Current Hypertension Reviews Palmitic Acid Grafted Maize Starch (PAgMS) Nanoparticles as Potential Drug Carrier for Irbesarten: In Vitro and In Vivo Evaluation
Current Nanomedicine Editorial (Thematic Issue: The (Same Old) Problem of Uncontrolled Hypertension)
Current Hypertension Reviews Nutrition and Nutraceuticals in Neuroinflammatory and Brain Metabolic Stress: Implications for Neurodegenerative Disorders
CNS & Neurological Disorders - Drug Targets Hypertension in the Elderly: An Evidence-based Review
Current Pharmaceutical Design Role of PI3K/AKT, cPLA2 and ERK1/2 Signaling Pathways in Insulin Regulation of Vascular Smooth Muscle Cells Proliferation
Cardiovascular & Hematological Disorders-Drug Targets Statins and Portal Hypertension: A New Pharmacological Challenge
Current Vascular Pharmacology Renal Function Impairment in Patients Undergoing Elective EVAR vs. Elective Open Repair During Follow up Period: A Systematic Review of the Literature
Current Vascular Pharmacology Characteristics Other than the Diagnostic Criteria Associated with Metabolic Syndrome: An Overview
Current Vascular Pharmacology Mitochondrially Targeted Antioxidants for the Treatment of Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery (Discontinued) Treatment of Hypertension in Heart Failure with Preserved Ejection Fraction
Current Hypertension Reviews Parental Hypertension and Cardiovascular Reactivity in Young Adults
Vascular Disease Prevention The Metabolic Syndrome From Pathophysiology to Novel Treatment Strategies
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents PPARγ Agonists: Beneficial Effect on Blood Pressure Beyond Glycemic Control?
Current Hypertension Reviews Role of Mechanical Stress in Monocytes / Macrophages: Implications for Atherosclerosis
Current Vascular Pharmacology Vascular Effects of Antiarrhythmic Drugs and the Roles of K+ Channels
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Introduction from the Guest Editor: The Many Facets of Heme Oxygenase
Current Neurovascular Research Intracranial Fluid Dynamics Changes in Idiopathic Intracranial Hypertension: Pre and Post Therapy
Current Neurovascular Research The Role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia
Current Pharmaceutical Biotechnology